中關村(000931.SZ):蘇雅醫藥取得CNAS實驗室認可證書
格隆匯9月22日丨中關村(000931.SZ)公佈,公司控股孫公司北京華素製藥股份有限公司之子公司北京蘇雅醫藥科技有限責任公司(簡稱“蘇雅醫藥”)已通過中國合格評定國家認可委員會(CNAS)的評審,並取得其授予的實驗室認可證書和認可決定書。
CNAS是由國務院認證認可監督管理部門確認的國家認可機構,統一負責對認證機構、實驗室和檢驗機構等相關機構的認可工作,其認可活動已經融入國際認可互認體系,可在認可的範圍內使用CNAS國家實驗室認可標誌、國際實驗室認可合作組織(ILAC)和亞太實驗室認可合作組織(APLAC)互認聯合標誌。
CNAS認證是從事檢測檢驗工作的國際通用衡量標準,通過這一認證,表明蘇雅醫藥具備了按照相應認可準則開展研究服務的技術能力,檢測質量獲得了行業主管機構及評審專家的認可。預計這一認證的通過,將能有效的增強公司的市場競爭能力,提升客户信心。同時,由於CNAS認證具備廣泛的國際互認,通過這一認證,對於蘇雅醫藥未來承接進口註冊項目、國際註冊項目,均能帶來良好的正面影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.